Raymond James Raises Procter & Gamble (NYSE:PG) Price Target to $165.00

Procter & Gamble (NYSE:PGGet Rating) had its target price upped by Raymond James from $155.00 to $165.00 in a research report sent to investors on Monday, Benzinga reports. They currently have an outperform rating on the stock.

Several other research firms have also recently issued reports on PG. JPMorgan Chase & Co. lowered their price objective on Procter & Gamble from $152.00 to $140.00 and set a neutral rating for the company in a research report on Thursday, October 13th. The Goldman Sachs Group cut Procter & Gamble from a buy rating to a neutral rating and set a $143.00 price objective for the company. in a research report on Sunday, October 9th. Credit Suisse Group decreased their target price on Procter & Gamble from $140.00 to $130.00 and set a neutral rating for the company in a research report on Tuesday, November 15th. Deutsche Bank Aktiengesellschaft upped their target price on Procter & Gamble from $155.00 to $156.00 and gave the company a buy rating in a research report on Thursday, October 20th. Finally, Truist Financial decreased their target price on Procter & Gamble from $175.00 to $160.00 and set a buy rating for the company in a research report on Monday, August 1st. Four analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of Moderate Buy and a consensus price target of $151.00.

Procter & Gamble Trading Up 0.6 %

NYSE:PG opened at $146.45 on Monday. The stock has a 50-day simple moving average of $133.59 and a 200-day simple moving average of $140.37. The stock has a market cap of $349.36 billion, a P/E ratio of 25.38, a P/E/G ratio of 4.18 and a beta of 0.41. Procter & Gamble has a 1 year low of $122.18 and a 1 year high of $165.35. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.41 and a current ratio of 0.62.

Procter & Gamble (NYSE:PGGet Rating) last released its quarterly earnings data on Wednesday, October 19th. The company reported $1.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.55 by $0.02. The business had revenue of $20.61 billion during the quarter, compared to analysts’ expectations of $20.37 billion. Procter & Gamble had a return on equity of 32.66% and a net margin of 18.11%. The business’s quarterly revenue was up 1.3% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.61 EPS. As a group, analysts anticipate that Procter & Gamble will post 5.83 earnings per share for the current fiscal year.

Procter & Gamble Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, November 15th. Shareholders of record on Friday, October 21st were paid a dividend of $0.9133 per share. The ex-dividend date was Thursday, October 20th. This is an increase from Procter & Gamble’s previous quarterly dividend of $0.91. This represents a $3.65 annualized dividend and a yield of 2.49%. Procter & Gamble’s dividend payout ratio is currently 63.26%.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, CEO R. Alexandra Keith sold 33,968 shares of the company’s stock in a transaction that occurred on Tuesday, November 8th. The stock was sold at an average price of $137.44, for a total transaction of $4,668,561.92. Following the completion of the sale, the chief executive officer now directly owns 38,990 shares of the company’s stock, valued at approximately $5,358,785.60. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other news, CEO R. Alexandra Keith sold 33,968 shares of the stock in a transaction that occurred on Tuesday, November 8th. The stock was sold at an average price of $137.44, for a total transaction of $4,668,561.92. Following the completion of the transaction, the chief executive officer now directly owns 38,990 shares of the company’s stock, valued at approximately $5,358,785.60. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Sundar G. Raman sold 14,922 shares of the stock in a transaction on Thursday, November 10th. The shares were sold at an average price of $139.60, for a total value of $2,083,111.20. Following the sale, the chief executive officer now owns 12,310 shares in the company, valued at approximately $1,718,476. The disclosure for this sale can be found here. Insiders sold a total of 58,812 shares of company stock valued at $8,190,363 in the last ninety days. Insiders own 0.26% of the company’s stock.

Institutional Investors Weigh In On Procter & Gamble

Several hedge funds have recently made changes to their positions in the business. Vanguard Group Inc. boosted its holdings in shares of Procter & Gamble by 1.0% during the third quarter. Vanguard Group Inc. now owns 224,570,227 shares of the company’s stock worth $28,351,991,000 after purchasing an additional 2,197,165 shares during the last quarter. BlackRock Inc. boosted its holdings in shares of Procter & Gamble by 1.1% during the third quarter. BlackRock Inc. now owns 161,904,833 shares of the company’s stock worth $20,440,487,000 after purchasing an additional 1,811,085 shares during the last quarter. State Street Corp raised its position in shares of Procter & Gamble by 0.8% in the 3rd quarter. State Street Corp now owns 104,749,256 shares of the company’s stock worth $13,224,594,000 after buying an additional 797,652 shares during the period. Bank of New York Mellon Corp raised its position in shares of Procter & Gamble by 4.3% in the 1st quarter. Bank of New York Mellon Corp now owns 23,740,255 shares of the company’s stock worth $3,627,510,000 after buying an additional 983,197 shares during the period. Finally, Legal & General Group Plc raised its position in shares of Procter & Gamble by 3.6% in the 2nd quarter. Legal & General Group Plc now owns 18,536,142 shares of the company’s stock worth $2,665,327,000 after buying an additional 637,095 shares during the period. Institutional investors and hedge funds own 63.45% of the company’s stock.

Procter & Gamble Company Profile

(Get Rating)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

See Also

Analyst Recommendations for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.